| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |